Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychophysiological characterization of the CNS action of Neurexan
2005-003942-32Phase 2Completed
- Sponsor
- Heel
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Neurexan in sleep disorder and anxiety disorder (2 arms), sponsored by Heel. Primary endpoint: Exploratory psychophysiological CNS measures. Started Oct 2005; status: completed.
02
Drugs
Neurexan
03
Conditions
sleep disorderanxiety disorder
Beyond the preview
Go deeper on 2005-003942-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003942-32.